Nightingale Health announces the development of innovative LLM based tool to empower anyone to take informed decisions to lower disease risks
Nightingale Health Plc
Press release
27 February 2025 at 2:15 p.m. (EET)
Nightingale Health Plc ("Nightingale Health"), a pioneer in disease risk detection and preventative health announces the development of an innovative LLM based tool to make its results report more interactive and actionable. The tool, powered by large language models (LLMs), leverages the multi-disease risk detection and blood value data from Nightingale Health's proprietary blood test and combines these with publicly available information about which lifestyle interventions most effectively reduce the risk of each disease.
The two key features of the LLM tool are helping each person to understand their disease risks more comprehensively without specialized training, and to connect life-style guidance to that person's individual situation. These key features are described below.
Interpretation
Medical data can be difficult to understand without specialized training. However, a significant amount of public information exists about the meaning of chronic disease risks and common blood values. Nightingale Health's custom LLM tool makes it easy for an individual to get answers to their questions and learn more about the advanced disease risk report and blood values. This empowers everyone to understand more about their personal health.
Guidance
Chronic disease risks can be reduced by well-known lifestyle interventions. However, general guidance tends to work poorly as it is hard to connect to a person's individual situation. A risk report based on information derived from a person's blood sample with tailored guidance makes it easier for them to understand their own situation and motivates them to act. Nightingale Health's custom LLM tool makes the connection between the risk profile, blood values and lifestyle choices easy to understand.
The tool can explain, for example, how lifestyle choices such as sleep and exercise impact the risk of diseases, such as cardiovascular disease risk or type 2 diabetes risk, and how lifestyle is also reflected in blood values such as lipids, sugar metabolism, or low-grade inflammation. In contrast to public health guidance, the information provided is relevant because it is based on person's own risk, and the user can receive guidance based on his or her own interest by choosing the questions for which guidance is requested. The tool is not intended to provide any medical interventions, which continue to be provided by healthcare professionals. People with high risk level or a diagnosed disease are always managed by healthcare professionals.
To enable population wide adoption, disease risk detection needs to be performed with minimal burden to healthcare professionals. The upcoming feature provides effective digital health guidance without requiring resources from the healthcare system.
"AI technologies have a huge potential to improve healthcare but only if the tools can be provided with inputs containing the necessary medical information. Combining the data in the risk report and blood test results with everything that is known about the preventative effects of healthy lifestyle choices and summarizing that in a concise and understandable way is a perfect use case for LLMs." says Antti Kangas, Nightingale Health's Chief Technology Officer. "We believe this custom LLM tool will have a crucial role in preventative healthcare, by enabling digital interpretation of test results and offering guidance that can be understood by anyone without specialized training."
"The core of preventative healthcare is the ability to detect disease risks population wide. Managing high-risk individuals is straightforward according to the medical guidelines, but it is equally important to empower everyone to become more aware of their individual health situation. Traditionally this has been overlooked, but combining LLM technologies with Nightingale Health's risk detection technology, anyone can make informed decisions about their personal health. This is a groundbreaking step towards creating smarter healthcare systems and healthier nations." says Teemu Suna, CEO and Founder of Nightingale Health.
Nightingale Health plans to launch its custom LLM tool in summer 2025 and the tool will be offered to Nightingale Health's B2B customers across different sectors in healthcare industry.
For further information, please contact:
Teemu Suna, CEO
ir@nightingalehealth.com
About Nightingale Health
Nightingale Health has developed the world's most advanced health check. Our solution provides risk detection for multiple chronic diseases from a single blood sample. Nightingale Health Check can be scaled to entire populations and it can replace many of the current routine disease risk assessments and health screening programs for chronic diseases. Detecting disease risks comprehensively and efficiently allows effective targeting and tracking of health interventions, and better prevention of chronic diseases. Nightingale Health's mission is to build sustainable healthcare and reduce health inequalities. With every sample we help to create a healthier world.
Nightingale Health operates globally with a parent company in Finland and eight subsidiaries in countries such as Japan, the United States, Singapore, and the United Kingdom. Nightingale Health has customers in more than 34 countries in the healthcare and medical research sectors. The company's technology is being used in many of the world's leading health initiatives, such as the UK Biobank, and over 600 peer-reviewed publications validate the technology. The company's Series B shares are listed on the First North Growth Market Finland marketplace. Read more: https://nightingalehealth.com/